Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company based in San Diego, California, focused on developing and commercializing products primarily in the therapeutic areas of allergy, respiratory diseases, and opioid overdose. The company's notable products include Symjepi, a pre-filled syringe for the emergency treatment of acute allergic reactions, including anaphylaxis. Additionally, Adamis is engaged in the development of various inhalers, such as a dry powder inhaler containing fluticasone for asthma, and a metered dose inhaler with beclomethasone. The company also has candidates for naloxone injections aimed at treating opioid overdose and Tadalafil for erectile dysfunction. Besides these, Adamis Pharmaceuticals offers a range of other pharmaceutical products, including corticosteroids, hormone replacement therapies, and various injectables for both human and veterinary use, addressing significant unmet medical needs across its therapeutic focus areas.